ArticleCPT: pharmacometrics & systems pharmacology2023

Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myeloma.

Jon Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.